Abstract:BackgroundWe compared the proportion of ischemic heart disease (IHD) patients newly diagnosed with dementia and depression across three treatment groups: percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG) and medical management alone (IHD-medical).Methods and FindingsDe-identified, individual-level administrative records of health service use for the population of Manitoba, Canada (approximately 1.1 million) were examined. From April 1, 1993 to March 31, 1998, patients were identi… Show more
“…We also included 2 further cohort studies16,17 comparing the risk of all-cause dementia and AD in those with CABG to those with PCI.…”
Section: Resultsmentioning
confidence: 99%
“…Our meta-analytic results suggest the significant association between history of CABG and dementia risk is unlikely to be driven by the underlying CAD as PCI may be associated with lower dementia risk compared with CABG. One study investigated dementia risk in those with a history of CABG compared with those receiving medical management for CAD and found no significant association, though this was limited by the use of medical records for the primary outcome 16. Further well-designed studies are needed to compare CABG with alternative treatment strategies for CAD.…”
Section: Discussionmentioning
confidence: 99%
“…A case-control study based on medical records15 did not find a significant association between CABG and odds of all-cause dementia and AD. Another medical records study investigated risk of all-cause dementia in those with CABG compared with those receiving medical management for CAD or those with PCI and found no significant associations 16. However, Lee et al17 also compared CABG to PCI in a medical records study and found a significantly increased risk of AD (Table 1).…”
“…We also included 2 further cohort studies16,17 comparing the risk of all-cause dementia and AD in those with CABG to those with PCI.…”
Section: Resultsmentioning
confidence: 99%
“…Our meta-analytic results suggest the significant association between history of CABG and dementia risk is unlikely to be driven by the underlying CAD as PCI may be associated with lower dementia risk compared with CABG. One study investigated dementia risk in those with a history of CABG compared with those receiving medical management for CAD and found no significant association, though this was limited by the use of medical records for the primary outcome 16. Further well-designed studies are needed to compare CABG with alternative treatment strategies for CAD.…”
Section: Discussionmentioning
confidence: 99%
“…A case-control study based on medical records15 did not find a significant association between CABG and odds of all-cause dementia and AD. Another medical records study investigated risk of all-cause dementia in those with CABG compared with those receiving medical management for CAD or those with PCI and found no significant associations 16. However, Lee et al17 also compared CABG to PCI in a medical records study and found a significantly increased risk of AD (Table 1).…”
“…4 However, a much larger subsequent Canadian population-based longitudinal study did not replicate this finding. 93 Several population epidemiological studies have recently been published, yielding conflicting and provocative results. Two Taiwanese studies drawn from national databases 94 95 and a large French population study 96 have all found a link between surgery or anaesthesia and subsequent incident dementia.…”
Section: Non-modifiable Factors: Age Genes and Dementiamentioning
Approximately a quarter of a billion people undergo surgery every year hoping that the operation will alleviate symptoms, cure diseases, and improve quality-of-life. A concern has arisen that, despite the benefits of surgery, elderly patients might suffer neurological injury from surgery and general anaesthesia leading to persistent cognitive decline. However, many studies of postoperative cognition have had methodological weaknesses, including lack of suitable control groups, dissociation of cognitive outcomes from surgical outcomes, sub-optimal statistical techniques, and absence of longitudinal preoperative cognitive assessments. Emerging evidence suggests that after early cognitive decline, most patients return to their preoperative cognitive trajectories within 3 months of surgery; some even experience subsequent cognitive improvement. In this review, we summarize the scientific literature on perioperative cognition. We propose that the most important determinants of the postoperative cognitive trajectory are the preoperative cognitive trajectory, the success of the surgery, and events in the perioperative period. Postoperative complications, ongoing inflammation, and chronic pain are probably modifiable risk factors for persistent postoperative cognitive decline. When surgery is successful with minimal perioperative physiological perturbations, elderly patients can expect cognition to follow its preoperative course. Furthermore, when surgery alleviates symptoms and enhances quality-of-life, postoperative cognitive improvement is a possible and desirable outcome.
“…First, the apolipoprotein E genotype associated with dementia is reportedly unrelated to POCD incidence in patients undergoing CABG surgery. 88 Second, a recent epidemiological study in Canada 89 reported that the proportion of patients with ischemic heart disease who subsequently received a diagnosis of dementia during 3 to 8 years of follow-up was 7.0% for those who were treated with CABG surgery and 12.1% for those who received conservative medical management only; this difference was not statistically significant.…”
Section: Preoperative Cognitive Variability -Chronic Influences On Brmentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.